Blood serum concentration of troponin in patients with COVID-19 of various severities

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: The search for available predictors of hospital survival and mortality rates during the COVID-19 pandemic is an urgent problem.

AIM: The study aimed to determine the role of troponin in the immediate prognosis of patients with COVID-19.

MATERIALS AND METHODS: The study included 85 patients with a new coronavirus infection upon admission, who underwent a blood test for troponin. All patients underwent an echocardiographic study according to a standard protocol, and the effect of troponin levels on nosocomial survival and mortality rates, correlation of this indicator with the left ventricular ejection fraction, degree of pulmonary hypertension, laboratory parameters, and degree of respiratory failure determined by computed tomography of the lungs and oxygen saturation indicators were analyzed. Correlation analysis with autopsy parameters was performed.

RESULTS: A high level of troponin indicated the worst prognosis of patients during hospitalization. The laboratory marker level correlated significantly with the parameters of the left ventricular ejection fraction. Its highest level was determined in patients with type 1 myocardial infarction. Troponin was not correlated with the degree of respiratory failure, as well as the state of the myocardium in the autopsy material.

CONCLUSIONS: Determining the troponin levels as a routine laboratory marker can be recommended for stratifying the risk of myocardial damage in patients with COVID-19 during hospitalization.

About the authors

Irina V. Kovtyukh

Petrovsky National Research Centre of Surgery

Author for correspondence.
Email: ivkovtuh@mail.ru
ORCID iD: 0000-0002-9176-1889
Russian Federation, 2, Abrikosovsky lane, GSP-1, Moscow, 119991

Gennady E. Gendlin

N.I. Pirogov Russian National Research Medical University

Email: rgmugt2@mail.ru
ORCID iD: 0000-0002-7846-1611

MD, Dr. Sci.(Med.), Professor

Russian Federation, Moscow

Igor G. Nikitin

N.I. Pirogov Russian National Research Medical University

Email: igor.nikitin.64@mail.ru
ORCID iD: 0000-0003-1699-0881

MD, Dr. Sci.(Med.), Professor

Russian Federation, Moscow

Aleksey E. Nikitin

Petrovsky National Research Centre of Surgery

Email: glavvrach@ckb.ru
ORCID iD: 0000-0001-5414-0250

MD, Dr. Sci. (Med.), Professor

Russian Federation, 2, Abrikosovsky lane, GSP-1, Moscow, 119991

Natalya L. Aleshenko

Petrovsky National Research Centre of Surgery

Email: nl.aleshenko@gmail.com
ORCID iD: 0000-0003-4891-9959
Russian Federation, 2, Abrikosovsky lane, GSP-1, Moscow, 119991

Olga A. Roginko

Petrovsky National Research Centre of Surgery

Email: 3115028@mail.ru
ORCID iD: 0000-0002-7356-7273
Russian Federation, 2, Abrikosovsky lane, GSP-1, Moscow, 119991

References

  1. Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130(4):304–309. doi: 10.20452/pamw.15272
  2. Porcheddu R, Serra C, Kelvin D, et al. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14(2):125–128. doi: 10.3855/jidc.12600
  3. Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262
  4. Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324–1329. doi: 10.1111/jth.14859
  5. Pranata R, Huang I, Lukito AA, Raharjo SB. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgrad Med J. 2020;96(1137):387–391. doi: 10.1136/postgradmedj-2020-137884
  6. Han H, Xie L, Liu R, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020;92(7):819–823. doi: 10.1002/jmv.25809
  7. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63(3):390–391. doi: 10.1016/j.pcad.2020.03.001
  8. Gaze DC. Clinical utility of cardiac troponin measurement in COVID-19 infection. Ann Clin Biochem. 2020;57(3):202–205. doi: 10.1177/0004563220921888
  9. Azevedo RB, Botelho BG, Hollanda JVG, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021;35(1):4–11. doi: 10.1038/s41371-020-0387-4
  10. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687. doi: 10.1093/cvr/cvaa106
  11. Chapman AR, Bularga A, Mills NL. High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19. Circulation. 2020;141(22):1733–1735. doi: 10.1161/CIRCULATIONAHA.120.047008
  12. Piccioni A, Brigida M, Loria V, et al. Role of troponin in COVID-19 pandemic: a review of literature. Eur Rev Med Pharmacol Sci. 2020;24(19):10293–10300. doi: 10.26355/eurrev_202010_23254
  13. Imazio M, Klingel K, Kindermann I, et al. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart. 2020;106(15):1127–1131. doi: 10.1136/heartjnl-2020-317186
  14. Nascimento JHP, Gomes BFO, Oliveira GMM. Cardiac Troponin as a Predictor of Myocardial Injury and Mortality from COVID-19. Arq Bras Cardiol. 2020;115(4):667–668. doi: 10.36660/abc.20200862
  15. Ozieranski K, Tyminska A, Jonik S, et al. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction? J Card Fail. 2021;27(1):92–96. doi: 10.1016/j.cardfail.2020.11.002
  16. Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020;95:304–307. doi: 10.1016/j.ijid.2020.04.061
  17. Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi: 10.1016/j.jinf.2020.04.021
  18. Lippi G, Cervellin G, Sanchis-Gomar F. Predicting mortality with cardiac troponins: recent insights from meta-analyses. Diagnosis (Berl). 2021;8(1):37–49. doi: 10.1515/dx-2019-0061
  19. Masri W, Le Guillou E, Hamdi E, et al. Troponin elevation in other conditions than acute coronary syndromes. Ann Biol Clin (Paris). 2017;75(4):411–419. doi: 10.1684/abc.2017.1262
  20. Markou N, Gregorakos L, Myrianthefs P. Increased blood troponin levels in ICU patients. Curr Opin Crit Care. 2011;17(5):454–463. doi: 10.1097/MCC.0b013e3283491f0d
  21. Eggers KM, Jernberg T, Lindahl B. Cardiac Troponin Elevation in Patients Without a Specific Diagnosis. J Am Coll Cardiol. 2019;73(1):1–9. doi: 10.1016/j.jacc.2018.09.082
  22. Fan Y, Zhao X, Li X, et al. Cardiac troponin and adverse outcomes in atrial fibrillation: A meta-analysis. Clin Chim Acta. 2018;477:48–52. doi: 10.1016/j.cca.2017.11.040
  23. Aikawa T, Takagi H, Ishikawa K, Kuno T. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: An insight from a meta-analysis. J Med Virol. 2021;93(1):51–55. doi: 10.1002/jmv.26108
  24. Larcher R, Besnard N, Akouz A, et al. Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med. 2021;10(8):1656. doi: 10.3390/jcm10081656
  25. Sandoval Y, Januzzi JL, Jr., Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76(10):1244–1258. doi: 10.1016/j.jacc.2020.06.068
  26. Zaninotto M, Mion MM, Padoan A, et al. Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoring. Clin Chim Acta. 2020;511:75–80. doi: 10.1016/j.cca.2020.09.036
  27. Al Abbasi B, Torres P, Ramos-Tuarez F, et al. Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality. Cardiol Res. 2020;11(6):398–404. doi: 10.14740/cr1159
  28. Li C, Jiang J, Wang F, et al. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol. 2020;147:74–87. doi: 10.1016/j.yjmcc.2020.08.008

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Effect of high-sensitivity troponin I concentration on the hospital survival rate of patients with COVID-19.

Download (69KB)
Indexing metadata
3. Fig. 2. ROC curves of the relationship between the prognosis of a lethal outcome and the level of high-sensitivity troponin I.

Download (46KB)
Indexing metadata

Copyright (c) 2022 Kovtyukh I.V., Gendlin G.E., Nikitin I.G., Nikitin A.E., Aleshenko N.L., Roginko O.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies